A Clinical Study of 9MW2821 in Advanced Malignant Solid Tumors

Clinical trial NCT05773937 · RECRUITING

Trial details

NCT number: NCT05773937
Sponsor: Mabwell (Shanghai) Bioscience Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Malignant Solid Tumors

Start date: 2022-06-21
Primary completion: 2024-12-31
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.